
### [NCIT:C6800](http://purl.obolibrary.org/obo/NCIT_C6800)
**Label:** Malignant Apocrine Neoplasm

**Subclasses:** [NCIT:C4169](http://purl.obolibrary.org/obo/NCIT_C4169) (Apocrine Carcinoma), [NCIT:C5457](http://purl.obolibrary.org/obo/NCIT_C5457) (Invasive Apocrine Breast Carcinoma), [NCIT:C40308](http://purl.obolibrary.org/obo/NCIT_C40308) (Vulvar Apocrine Adenocarcinoma), [NCIT:C5140](http://purl.obolibrary.org/obo/NCIT_C5140) (Apocrine Breast Carcinoma In Situ), [NCIT:C5141](http://purl.obolibrary.org/obo/NCIT_C5141) (Apocrine Breast Carcinoma), 

**Class expressions from DL-Learner:**

- [NCIT:C62500](http://purl.obolibrary.org/obo/NCIT_C62500) (Malignant Apocrine Cell) and (not ([NCIT:C36908](http://purl.obolibrary.org/obo/NCIT_C36908) (Apocrine Carcinoma Cell))) 54.55%
- Thing 52.66%
- [NCIT:C62494](http://purl.obolibrary.org/obo/NCIT_C62494) (Neoplastic Apocrine Cell) 49.92%
- [NCIT:C62500](http://purl.obolibrary.org/obo/NCIT_C62500) (Malignant Apocrine Cell) 39.90%
- [NCIT:C36807](http://purl.obolibrary.org/obo/NCIT_C36807) (Dysplastic Epithelial Cell) and [NCIT:C62494](http://purl.obolibrary.org/obo/NCIT_C62494) (Neoplastic Apocrine Cell) 39.90%
- [NCIT:C36779](http://purl.obolibrary.org/obo/NCIT_C36779) (Malignant Epithelial Cell) and [NCIT:C62494](http://purl.obolibrary.org/obo/NCIT_C62494) (Neoplastic Apocrine Cell) 39.90%
- [NCIT:C12917](http://purl.obolibrary.org/obo/NCIT_C12917) (Malignant Cell) and [NCIT:C62494](http://purl.obolibrary.org/obo/NCIT_C62494) (Neoplastic Apocrine Cell) 39.90%
- [NCIT:C62500](http://purl.obolibrary.org/obo/NCIT_C62500) (Malignant Apocrine Cell) and (not ([NCIT:C39897](http://purl.obolibrary.org/obo/NCIT_C39897) (Prostate Ductal Adenocarcinoma, Solid Pattern))) 39.90%
- [NCIT:C62500](http://purl.obolibrary.org/obo/NCIT_C62500) (Malignant Apocrine Cell) and (not ([NCIT:C39896](http://purl.obolibrary.org/obo/NCIT_C39896) (Prostate Ductal Adenocarcinoma, Papillary Pattern))) 39.90%
- [NCIT:C62500](http://purl.obolibrary.org/obo/NCIT_C62500) (Malignant Apocrine Cell) and (not ([NCIT:C39895](http://purl.obolibrary.org/obo/NCIT_C39895) (Prostate Ductal Adenocarcinoma, Cribriform Pattern))) 39.90%
- [NCIT:C62500](http://purl.obolibrary.org/obo/NCIT_C62500) (Malignant Apocrine Cell) and (not ([NCIT:C3989](http://purl.obolibrary.org/obo/NCIT_C3989) (Parathyroid Hyperplasia))) 39.90%
- [NCIT:C62500](http://purl.obolibrary.org/obo/NCIT_C62500) (Malignant Apocrine Cell) and (not ([NCIT:C39885](http://purl.obolibrary.org/obo/NCIT_C39885) (Acinar Prostate Adenocarcinoma, Lymphoepithelioma-Like Variant))) 39.90%
- [NCIT:C62500](http://purl.obolibrary.org/obo/NCIT_C62500) (Malignant Apocrine Cell) and (not ([NCIT:C39880](http://purl.obolibrary.org/obo/NCIT_C39880) (Acinar Prostate Adenocarcinoma, Atrophic Variant))) 39.90%
- [NCIT:C62500](http://purl.obolibrary.org/obo/NCIT_C62500) (Malignant Apocrine Cell) and (not ([NCIT:C39875](http://purl.obolibrary.org/obo/NCIT_C39875) (Loss of Chromosome 9q))) 39.90%
- [NCIT:C62500](http://purl.obolibrary.org/obo/NCIT_C62500) (Malignant Apocrine Cell) and (not ([NCIT:C39874](http://purl.obolibrary.org/obo/NCIT_C39874) (Urethral Verrucous Carcinoma))) 39.90%


